NEW YORK, Feb. 24 (GenomeWeb News) - Shares in Nanogen were down 6.67 percent, or $.29, at $4.07 in late-afternoon trading after the company yesterday reported a 51-percent fall-off in fourth-quarter revenue and an 89-percent increase in its net losses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.